Filter
341
Text search:
infographic
Featured
Recommendations
54
New Publications
73
Language
Document type
Infographics
114
No document type
105
Studies & Reports
30
Guidelines
27
Manuals
18
Fact sheets
16
Resource Platforms
9
Training Material
7
Situation Updates
6
Strategic & Response Plan
6
Videos
2
Dashboards/Maps
1
Countries / Regions
Germany
16
Global
14
Congo, Democratic Republic of
11
Syria
10
South Africa
6
Singapore
5
Yemen
5
Sierra Leone
4
Liberia
4
Ethiopia
4
South Sudan
4
Kenya
4
Guinea
3
Nigeria
3
Uganda
3
Philippines
3
India
3
Central African Republic
3
Ukraine
3
Burkina Faso
2
Senegal
2
Ghana
2
Haiti
2
Somalia
2
Nepal
2
Pakistan
2
Afghanistan
2
Zambia
2
Tanzania
2
Cambodia
2
Rwanda
2
Malawi
2
Lesotho
2
Chile
2
South–East Asia Region
2
Western and Central Europe
2
Africa
2
Venezuela
2
Moldova
2
United Kingdom
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Togo
1
Zimbabwe
1
Iraq
1
Turkey
1
Chad
1
Indonesia
1
Malaysia
1
Bangladesh
1
Sudan
1
Argentina
1
Peru
1
Brazil
1
Hungary
1
Burundi
1
Colombia
1
Ecuador
1
Myanmar / Burma
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Latin America and the Carribbean
1
Poland
1
Palestine
1
Italy
1
Laos
1
Russia
1
Romania
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
95
Key Resources
25
Clinical Guidelines
23
Women & Child Health
7
Capacity Building
4
Public Health
3
Pharmacy & Technologies
2
Toolboxes
COVID-19
87
Ebola & Marburg
30
Caregiver
22
Conflict
16
Rapid Response
16
Mental Health
16
Zika
14
Planetary Health
13
NTDs
11
Disability
10
AMR
10
Malaria
9
2.0 Rapid Response
9
Refugee
8
Global Health Education
8
HIV
5
Specific Hazards
4
NCDs
4
Cholera
3
Natural Hazards
3
Polio
1
Pharmacy
1
Health Financing Toolbox
1
Cocktail d’anticorps monoclonaux neutralisant REGN-EB3 contre la maladie à virus Ebola (MVE)
recommended
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
ORGANISMOS DE PROTECCIÓN DE DERECHOS DE NIÑAS, NIÑOS Y ADOLESCENTES (NNA)
The document provides inforation on tobacco use (health effects, quitting, benefits of quitting, e-cigarettes etc.) in a descriptive way.
Close to 800 000 people die due to suicide every year, which is one person every 40 seconds. Suicide is a global phenomenon and occurs throughout the lifespan. Effective and evidence-based interventions can be implemented at population, sub-population and individual levels to prevent suicide and sui
...
Policy considerations for the WHO European Region
24 April 2020
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Download Kiswahili or English frequently asked questions about PrEP.
If you think you might have monkeypox, self-isolate and contact a health worker immediately. If your symptoms become worse, seek immediate medical advice
It takes just 5 moments to change the world. Clean your hands, stop the spread of drug-resistant germs!
Solo se necesitan 5 momentos para cambiar el mundo. Limpia tus manos, detén la propagación de gérmenes multirresistentes !
Antibiotic resistance is a natural occurrence caused by mutations in bacteria’s genes. However, inappropriate use of antibiotics accelerates the emergence and spread of antibiotic-resistant bacteria. When exposed to antibiotics, susceptible bacteria are killed; while excessive antibiotic use or th
...
Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden of infections with bacteria resistant to antibiotics on the European population is comparable to that of influenza, tuberculosis and HIV/AIDS combined.
Based on scientific evidence, expert consensus and country experiences, the WHO core components for infection prevention and control (IPC) are the foundation for establishing or strengthening effective programmes at the national and facility level.
These new guidelines on core components of infecti
...
